FAIM
BCRX icon

Financial Advocates Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Financial Advocates Investment Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,708
Closed -$369K – 760
2022
Q3 		$369K Buy
+12,708
New +$369K 0.03% 489